Table 5. Diagnostic performance of autoantibodies against HSP70, RNH1 and ENO1 in pairwise comparisons between CCA, cholangitis, or healthy controls.
Diagnosis | AUC | Cutoff (OD) | Sensitivity (%) | 95%CI | Specificity (%) | 95% CI | P-value |
Healthy vs CCA | |||||||
HSP70 | 0.9158 | 0.2630 | 93.55 | 78.58−99.21 | 73.91 | 51.60−89.77 | <0.0001 |
ENO1 | 0.8576 | 0.7185 | 80.65 | 62.53−92.55 | 78.26 | 56.30−92.54 | <0.0001 |
RNH1 | 0.8380 | 0.5615 | 93.55 | 78.58−99.21 | 66.67 | 44.68−84.37 | <0.0001 |
Healthy vs cholangitis | |||||||
HSP70 | 0.8170 | 0.2695 | 75 | 42.81−94.51 | 73.91 | 51.60−89.77 | 0.002 |
ENO1 | 0.8043 | 0.7380 | 75 | 42.81−94.51 | 78.26 | 56.30−92.54 | 0.003 |
RNH1 | 0.7790 | 0.5785 | 83.33 | 51.59−97.91 | 65.22 | 42.73−83.62 | 0.007 |
Cholangitis vs CCA | |||||||
HSP70 | 0.7191 | 0.4800 | 51.61 | 33.06−69.85 | 83.33 | 51.59−97.91 | 0.02 |
AUC = area under the curve, 95%CI = 95% confidence interval (lower-upper).